in-person Meeting Information
Our meetings are free and open to all. No registration required, just show up!
Video of the meetings are available on our IPCSG YouTube channel the week following the meetings.
https://www.youtube.com/@ProstateCancerSupport
As always, spouses/partners and caregivers are welcome and encouraged to attend!
Sanford Burnham Prebys Medical Discovery Institute (Building 12)
10905 Rd to the Cure, San Diego, CA 92121
(Press the button below, enter your location then press enter)
November 16, 2024 10am pt
November meeting canceled
Due to unforeseen circumstances, the November IPCSG meeting has been canceled.
Next meeting will be January 18, 2025.
october 19, 2024 10AM PT
TREATMENTS FOR ADVANCED PROSTATE CANCER
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.
Dr. McKay leads a multi-disciplinary prostate cancer clinic focused on delivering advanced cancer care through a coordinated team approach.
Dr. McKay will be highlighting recent FDA approved treatments for advanced prostate cancer. Additionally, she will discuss current novel treatments that are in development and clinical trials of the next generation treatments for prostate cancer.
september 21, 2024 10AM PT
THE ROLE OF PROTON THERAPY IN THE MANAGEMENT OF SOLID TUMORS: CURRENT STATE AND FUTURE DIRECTIONS
Dr. Ramesh Rengan is currently the Peter Wootton Chair and Professor in the Department of Radiation Oncology at the University of Washington School of Medicine and the Senior Vice President and Director in Radiation Oncology Division at the Fred Hutchinson Cancer Center. He also holds a joint appointment as faculty of the Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center.
His clinical interests include thoracic malignancies, melanomas (including ocular melanoma), renal cell carcinoma, and prostate cancer. Additionally, he has clinical expertise in the use of proton beam therapy in the management of localized and locally advanced solid tumors. His research interests include approaches to improve the therapeutic ratio in solid tumors to ionizing photon or proton radiation, pre-clinical and clinical strategies to utilize radiation to trigger an anti-tumor immune response in patients with advanced solid malignancies.
He also has an interest in healthcare disparities and expanded access to radiation treatment in low-resource environments and Photon- and Proton based radiation regimens to trigger an immune response to augment immunotherapeutic platforms in solid malignancies including NSCLC, melanoma, lymphoma, and renal cell carcinoma.
August 17, 2024 10AM PT
Future of Precision Medicine – Prostate Cancer
Denise Guilbault from Telix pharmaceuticals will give a presentation on their new Lutetium based therapy and their current diagnostic tools.
Telix, based in Australia, is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.
Denise is a Medical Science Liaison with a decade of successful experience in supporting drug development from pre-launch to post marketing research in the solid tumor space, focusing on prostate cancer, breast cancer, and melanoma, . Previously, she worked for two decades in nuclear medicine imaging and patient care in the imaging suite. She now works directly with researchers in enrolling patients into Telix-sponsored trials and in supporting investigator-initiated studies.
For more information, visit their website: https://telixpharma.com/
July 20, 2024 10am pt
ROUNDTABLE
Three members of the IPCSG group will share stories about their journey with Prostate Cancer.
- Bill Manning
- Mike McCarey
- Herschel Kagan
This is your chance to get all your questions answered by men who have
"been there, done that".
March 16, 2024 10AM PT
Dr. Kipper - PET/CT imaging technology
Dr. Kipper is one of the nation’s foremost experts in PET/CT imaging technology for the diagnosis of cancer and brain disorders. He is the author of several medical textbooks and numerous professional journal articles on imaging techniques for the evaluation of cancer and other disease processes.
February 17, 2024 10AM PT
IPCSG Roundtable
Three members of the IPCSG group will share stories about their journey with Prostate Cancer.
- Dennis Hickey
- Don Wang
- North County Cancer Fitness - Karla Going President
This is your chance to get all your questions answered by men who have
"been there, done that".
January 20, 2024 10AM PT
Dr. A. J. Mundt MD,
UCSD Radiation Oncology
Updates on Radiation Oncology
Arno J. Mundt, MD, FACRO, FASTRO
- Radiation Oncologist and Professor and Chair of Radiation Medicine and Applied Sciences
- Dr. Mundt will be introducing the other speakers and giving an introductory overview of radiation oncology as it relates to prostate cancer.
Other speakers to be announced.
December 2023
No Meeting in December
The IPCSG team wishes you and your loved ones a very Merry Christmas filled with love, laughter, and good health.
We are looking forward to a happy and healthy 2024 for all!
November 18, 2023 10:00AM PT
Sam Denmeade, M.D. - bipolar androgen therapy (BAT)
Dr. Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer.
He will be discussing Bipolar Androgen Therapy (BAT), a new endocrinologic treatment for castration-resistant prostate cancer (CRPC). BAT is a treatment in which testosterone levels are oscillated between low and high levels in order to prevent the adaptation of prostate cancer cells to a low-androgen environment.
Dr. Rana McKay
October 21, 2023 10:00 AM PT
“Novel Therapeutic Strategies for Patients with Advanced Prostate Cancer”
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.
Dr. McKay leads a multi-disciplinary prostate cancer clinic focused on delivering advanced cancer care through a coordinated team approach.
Dr. McKay will be highlighting recent FDA approved treatments for advanced prostate cancer. Additionally, she will discuss current novel treatments that are in development and clinical trials of the next generation treatments for prostate cancer.
September 16, 2023 10:00AM PT
Dean Hall - Swimming In Miracles
Dean is a licensed clinical therapist and coach with over 30 years of experience, an author and highly sought-after speaker, a two-time cancer survivor who experienced radical remission from leukemia and lymphoma, and a two-time world record-setting extreme distance swimmer.
He is the first person in history to swim the entire 187-mile length of Oregon’s longest river, the Willamette River, (which he did as an active cancer patient) in 2014, and Ireland’s longest river, the River Shannon (180 miles), in 2017.
IPCSG Roundtable
August 19, 2023 10:00 AM PT
Members of the IPCSG group will share stories about their journey with Prostate Cancer.
This is a great time to ask your questions from men who have gone through different treatments, their successes', difficulties and lessons learned.
A combined Q&A session will occur after all 3 have spoken.
This is your chance to get all your questions answered by men who have
"been there, done that".
See it, Treat it The Telix Pipeline
July 15, 2023, 10:00AM PT
Mary Hames, PhD, EMBA, holds a BS and MS in Chemistry, an interdisciplinary PhD in Biochemistry, Genetics, and Chemical Engineering from the University of Alabama Huntsville and an Executive MBA from Kennesaw State.
She is now the US Medical Director for Telix pharmaceuticals, and manages the US Field Medical Team which functions to educate US HCP’s on Telix’s commercially approved products as well as their pipeline diagnostics and therapeutics.
Laser Focal Therapy and Genomic Testing
June 17, 2023, 10:00AM PT
Bernadette M. Greenwood Chief Research Officer at HALO Diagnostics will be presenting the history, updates and results of the focal therapy clinical trial NCT 02243033 (LINK) that she and her team have been conducting.
She will be joined by Dr. Aaron Harman, who will share some real-life scenarios as case studies.
Decipher (Veracyte Labs SD) will also be on-hand to provide information and answers regarding tissue-based genomics.
May 20, 2023, 10:00AM PT
Our May meeting will be a double header covering 2 very important and timely subjects:
- Provenge Immunotherapy - is a personalized immunotherapy that activates the immune system to help fight advanced prostate cancer and has been proven to help certain men live longer. It works differently from other cancer treatments, such as chemotherapy or hormone therapy.
- Sparrow Search - is a patient-friendly search engine that allows patients to directly search for and match to clinical trials. Patients who match to clinical trials are connected with clinical research sites, thereby increasing the pool of potential study candidates and expediting the recruitment process.
april 15, 2023, 10:00AM PT
The Medical Journey of a Prostate Cancer Patient
Dr. Richard Lam will be our speaking at the April 15 IPCSG meeting. Dr. Lam is a double board-certified internist and oncologist, who has been specializing in the treatment of prostate cancer since 2001 at Prostate Oncology Specialists in Marina del Rey, California.
HIs presentation will include updates on the latest trials, testing and treatment options available for prostate cancer patients. As always, his presentations are very informative and presented in an easily understood format. He also brings a great wit with a touch of humor.
March 18, 2023
Dr. Paul Dato
Director, Genesis Healthcare
Prostate Cancer Tests
Dr. Paul Dato is a urologist and currently serves as Director for Medical Quality and Director of the Prostate Cancer Center for Genesis healthcare.
Dr. Dato will be discussing New Prostate Cancer Tests…and some Old Ones